CYP2D6 and Parkinson disease: DNM1L is also closely related to the metabolism of exogenous substances and drug metabolism of cytochrome P450 (CYP450), and mitochondria-targeted cytochrome P450 2D6 (CYP2D6) can efficiently catalyze the MPTP compounds that may induce Parkinson’s disease in humans (39).